The Food and Drug Administration has come under fire for a recent move that relaxes a key goal of the “Make America Healthy ...
Moderna said it met with the FDA on Tuesday to discuss the vaccine and afterward, the U.S. regulator accepted a revised ...
Experts say new labeling could deceive consumers as dangerous substances still allowed under new rules ...
GlobalData on MSN
FDA to allow one pivotal trial instead of two for drug approval
Prasad and Makary disagree that some may believe this move shows the FDA relaxing its standards.
Thousands of units have were potentially contaminated with a radioactive substance, which can increase the risk of cancer.
The Food and Drug Administration's about-face comes a little more than a week after the agency refused to consider the ...
The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...
Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and ...
The agency could by late December approve a therapy that Roche sees as potentially becoming a new treatment standard for ...
All this means other unknown additional allergens were included in the batch, too—making this a serious health concern for ...
The Food and Drug Administration (FDA) has backtracked its initial decision last week of refusing to review Moderna’s mRNA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results